PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
49.06
ESG score below 80% of ADAP's 62.74. Jim Chanos would check for potential ESG-related litigation and regulatory risks.
63.54
Environmental score exceeding 1.2x ADAP's 50.00. Mohnish Pabrai would examine if this environmental advantage creates sustainable cost advantages.
31.02
Social score below 80% of ADAP's 78.41. Jim Chanos would check for potential social license and litigation risks.
52.63
Governance score 80-90% of ADAP's 59.80. Walter Schloss would scrutinize management accountability and board independence.